These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 2969772)
61. Prolactin response to fenfluramine and placebo challenge following maintenance pharmacotherapy withdrawal in remitted depressed patients. Shapira B; Cohen J; Newman ME; Lerer B Biol Psychiatry; 1993 Apr; 33(7):531-5. PubMed ID: 8513038 [TBL] [Abstract][Full Text] [Related]
62. Dysregulation of the hypothalamo-pituitary axis in rheumatoid arthritis. Jorgensen C; Bressot N; Bologna C; Sany J J Rheumatol; 1995 Oct; 22(10):1829-33. PubMed ID: 8991978 [TBL] [Abstract][Full Text] [Related]
63. Hormone response to repeated electroconvulsive therapy: effects of naloxone. Haskett RF; Zis AP; Albala AA Biol Psychiatry; 1985 Jun; 20(6):623-33. PubMed ID: 2986737 [TBL] [Abstract][Full Text] [Related]
64. Endocrine responses to thyrotropin-releasing hormone in major depressive disorders. Asnis GM; Sachar EJ; Halbreich U; Nathan RS; Ostrow L; Soloman M; Halpern FS Psychiatry Res; 1981 Oct; 5(2):205-15. PubMed ID: 6117098 [TBL] [Abstract][Full Text] [Related]
65. Fenfluramine and idiopathic pain: a serotonergic study in non-psychiatric patients with functional gastrointestinal disorder. Tanum L; Bråtveit-Johansen K; Malt UF Scand J Gastroenterol; 1998 Jul; 33(7):684-90. PubMed ID: 9712230 [TBL] [Abstract][Full Text] [Related]
66. 5-HT brain function in affective disorder: d,l-fenfluramine-induced hormone release and clinical outcome in long-term lithium/carbamazepine prophylaxis. Mannel M; Müller-Oerlinghausen B; Czernik A; Sauer H J Affect Disord; 1997 Nov; 46(2):101-13. PubMed ID: 9479614 [TBL] [Abstract][Full Text] [Related]
67. Hormonal responses to zimelidine and desipramine in depressed patients. Calil HM; Lesieur P; Gold PW; Brown GM; Zavadil AP; Potter WZ Psychiatry Res; 1984 Nov; 13(3):231-42. PubMed ID: 6098913 [TBL] [Abstract][Full Text] [Related]
68. Neuroendocrine responses in chronic schizophrenia. Evidence for serotonergic dysfunction. Lerer B; Ran A; Blacker M; Silver H; Weller MP; Drummer D; Ebstein B; Calev A Schizophr Res; 1988; 1(6):405-10. PubMed ID: 3154528 [TBL] [Abstract][Full Text] [Related]
69. Determination of prolactin, growth hormone, beta-endorphin, and cortisol in both maternal plasma and amniotic fluid during human gestation. Kubota T; Tsuzuki H; Saito M Acta Endocrinol (Copenh); 1989 Aug; 121(2):297-303. PubMed ID: 2528262 [TBL] [Abstract][Full Text] [Related]
70. Effect of exogenous beta-endorphin on anterior pituitary hormone secretion in man. Oyama T; Yamaya R; Jin T; Kudo T Acta Endocrinol (Copenh); 1982 Jan; 99(1):9-13. PubMed ID: 6277126 [TBL] [Abstract][Full Text] [Related]
71. Prolactin and cortisol responses to acute intravenous clomipramine challenge in patients with mania, depression and healthy controls: evidence for reduced serotonergic responsivity. Lykouras L; Markianos M; Hatzimanolis Y Neuropsychobiology; 2011; 63(2):77-81. PubMed ID: 21178381 [TBL] [Abstract][Full Text] [Related]
72. Effects of naloxone on prolactin, growth hormone and cortisol response to insulin hypoglycemia in obese subjects. Papalia D; Lunetta M; Di Mauro M J Endocrinol Invest; 1989 Dec; 12(11):777-82. PubMed ID: 2693516 [TBL] [Abstract][Full Text] [Related]
73. Differential response of growth hormone, cortisol, and prolactin to seizures and to stress. Culebras A; Miller M; Bertram L; Koch J Epilepsia; 1987; 28(5):564-70. PubMed ID: 3653062 [TBL] [Abstract][Full Text] [Related]
74. Elevated cortisol concentrations and the diminished prolactin response to fenfluramine. Mitchell PB; Smythe GA Am J Psychiatry; 1992 Jun; 149(6):851-2. PubMed ID: 1590517 [No Abstract] [Full Text] [Related]
75. Prolactin and cortisol responses to fenfluramine challenge in mania. Yatham LN Biol Psychiatry; 1996 Feb; 39(4):285-8. PubMed ID: 8645775 [TBL] [Abstract][Full Text] [Related]
76. Prolactin response to dl-fenfluramine challenge before and after treatment with paroxetine. Dulchin MC; Oquendo MA; Malone KM; Ellis SP; Li S; Mann JJ Neuropsychopharmacology; 2001 Sep; 25(3):395-401. PubMed ID: 11522467 [TBL] [Abstract][Full Text] [Related]
77. Immunoendocrine aspects of anorexia nervosa. Brambilla F; Ferrari E; Brunetta M; Peirone A; Draisci A; Sacerdote P; Panerai A Psychiatry Res; 1996 Apr; 62(1):97-104. PubMed ID: 8739119 [TBL] [Abstract][Full Text] [Related]